Low vision depression prevention trial in age-related macular degeneration: A randomized clinical trial

Ophthalmology

Volumn 121, Issue 11, 2014, Pages 2204-2211

  Rovner, Barry W ^a   Casten, Robin J ^a   Hegel, Mark T ^b   Massof, Robert W ^c   Leiby, Benjamin E ^d   Ho, Allen C ^d   Tasman, William S ^d  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; BEHAVIOR; BEHAVIOR ACTIVATION; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DSM-IV; EMOTIONALITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOW VISION; LOW VISION REHABILITATION; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OPTOMETRY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT HEALTH QUESTIONNAIRE 9; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION; RISK ASSESSMENT; SOCIAL BEHAVIOR; SOCIAL SUPPORT; SUPPORTIVE THERAPY; THERAPY EFFECT; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; COMPARATIVE STUDY; DEPRESSIVE DISORDER; HEALTH STATUS INDICATOR; MACULAR DEGENERATION; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; SICKNESS IMPACT PROFILE; SINGLE BLIND PROCEDURE; VERY ELDERLY; VISION, LOW;

AGED; AGED, 80 AND OVER; BEHAVIOR THERAPY; DEPRESSIVE DISORDER; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MACULAR DEGENERATION; MALE; PERSONALITY INVENTORY; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SINGLE-BLIND METHOD; SURVEYS AND QUESTIONNAIRES; VISION, LOW; VISION, OCULAR; VISUAL ACUITY;

EID: 84908485967     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.05.002     Document Type: Article

References (42)

1. R. Klein, C.F. Chou, and B.E. Klein Prevalence of age-related macular degeneration in the US population Arch Ophthalmol 129 2011 75 80
2. D.R. Rein, J.S. Wittenborn, and X. Zhang Vision Health Cost-Effectiveness Study Group. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments Arch Ophthalmol 127 2009 533 540
3. P. Rosenfeld, D. Brown, J. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
4. F.A. Sloan, and B.W. Hanrahan The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration JAMA Ophthalmol 132 2014 456 463
5. S. Soubrane, A. Cruess, and A. Lotery Burden and health care resource utilization in neovascular age-related macular degeneration Arch Ophthalmol 125 2007 1249 1254
6. A. Wysong, P.P. Lee, and F.A. Sloan Longitudinal incidence of adverse outcomes of age-related macular degeneration Arch Ophthalmol 127 2009 320 327
7. R.C. Casten, and B.W. Rovner Update on depression and age-related macular degeneration Curr Opin Ophthalmol 24 2013 239 243
8. A. Horowitz, J.P. Reinhardt, and G.J. Kennedy Major and subthreshold depression among older adults seeking vision rehabilitation services Am J Geriatr Psychiatry 13 2005 180 187
9. M. Hamer, C.J. Bates, and G.D. Mishra Depression, physical function, and risk of mortality: National Diet and Nutrition Survey in adults older than 65 years Am J Geriatr Psychiatry 19 2011 72 78
10. B. Lebowitz, J. Pearson, and L. Schneider Diagnosis and treatment of depression in late life: consensus statement and update JAMA 278 1997 1186 1190
11. J.W. Kanter, R.C. Manos, and W.M. Bowe What is behavioral activation? A review of the empirical literature Clin Psychol Rev 30 2010 608 620
12. P.N. Novalis, S.J. Rojcewicz, and R. Peele Clinical Manual of Supportive Psychotherapy 1993 American Psychiatric Press Washington, DC 3 7
13. K. Kroenke, R.L. Spitzer, and J.B. Williams The PHQ-9: validity of a brief depression severity measure J Gen Intern Med 16 2001 606 613
14. Diagnostic and Statistical Manuel of Mental Disorders: DSM-IV 4th ed. 1994 American Psychiatric Association Washington, DC
15. F.M. Reischies, and B. Geiselmann Age-related cognitive and vision impairment affecting the detection of dementia syndrome in old age Br J Psychiatry 171 1997 449 451
16. E.L. Lamoureux, H.W. Tee, and K. Pesudovs Can clinicians use the PHQ-9 to assess depression in people with vision loss? Optom Vis Sci 86 2009 139 145
17. R.W. Massof, L. Ahmadian, and L.L. Grover The Activity Inventory: an adaptive visual function questionnaire Optom Vis Sci 84 2007 763 774
18. C.M. Mangione, P.P. Lee, P.R. Gutierrez National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058
19. R.W. Massof, and J.A. Stelmack Interpretation of low-vision rehabilitation outcome measures Optom Vis Sci 90 2013 788 798
20. M. Von Korff, E.H. Wagner, and K. Saunders A chronic disease score from automated pharmacy data J Clin Epidemiol 45 1992 197 203
21. J.E. Ware, E.C. Nelson, C.D. Sherbourne, and A.L. Stewart Preliminary tests of a 6-item general health survey: A patient application A.L. Stewart, J.E. Ware Jr. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach 1992 Duke University Press Durham, NC 291 308
22. R.R. McCrae, and P.T. Costa Personality in Adulthood 1990 Guilford Press New York 41 51
23. J.W. Kanter, P.S. Mulick, and A.M. Busch The Behavioral Activation for Depression Scale (BADS): psychometric properties and factor structure J Psychopathol Behav Assess 29 2007 191 202
24. G. Zou A modified Poisson regression approach to prospective studies with binary data Am J Epidemiol 159 2004 702 706
25. A.T. Galecki General class of covariance structures for two or more repeated factors in longitudinal data analysis Commun Stat Theory Methods 23 1994 3105 3119
26. R. Thiébaut, H. Jacqmin-Gadda, and G. Chêne Bivariate linear mixed models using SAS Proc MIXED Comput Methods Programs Biomed 69 2002 249 256
27. D. Iacobucci, N. Saldanha, and X. Deng A meditation on mediation: evidence that structural equations models perform better than regressions J Consum Psychol 17 2007 139 153
28. B.W. Rovner, R.J. Casten, and M.T. Hegel Preventing depression in age-related macular degeneration Arch Gen Psychiatry 64 2007 886 892
29. R. Casten, B.W. Rovner, B.E. Lieby, and W. Tasman Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration [letter] Arch Ophthalmol 128 2010 506 507
30. J.A. San Laureano, E.M. Briganti, and D.J. Colville Number needed to treat: a useful new method of assessing the magnitude of treatment effect and its application to the management of diabetic retinopathy Aust N Z J Ophthalmol 27 1999 137 142
31. J.A. Stelmack, T.R. Stelmack, and R.W. Massof Measuring low-vision rehabilitation outcomes with the NEI VFQ-25 Invest Ophthalmol Vis Sci 43 2002 2859 2868
32. M. Marella, K. Pesudovs, and J.E. Keeffe The psychometric validity of the NEI VFQ-25 for use in a low-vision population Invest Ophthalmol Vis Sci 51 2010 2878 2884
33. C. Montlahuc, A. Soumaré, and A. Dufouil Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C Study Neurology 77 2011 1457 1464
34. J.A. Stelmack, X.C. Tang, D.J. Reda LOVIT Study Group Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT) Arch Ophthalmol 126 2008 608 617
35. A. Horowitz, M. Brennan, J.P. Reinhardt, and T. MacMillan The impact of assistive device use on disability and depression among older adults with age-related vision impairments J Gerontol B Psychol Sci Soc Sci 61 2006 S274 S280
36. B.L. Brody, A.C. Roch-Levecq, and A.C. Gamst Self-management of age-related macular degeneration and quality of life Arch Ophthalmol 120 2002 1477 1483
37. B.W. Rovner, R.J. Casten, and M.T. Hegel Improving function in age-related macular degeneration: a randomized clinical trial Ophthalmology 120 2013 1649 1655
38. P. Cuijpers, A.T. Beekman, and C.F. Reynolds III Preventing depression: a global priority JAMA 307 2012 1033 1034
39. B.L. Lam, S.L. Christ, and D.J. Lee Reported visual impairment and risk of suicide: the 1986-1996 National Health Interview surveys Arch Ophthalmol 126 2008 975 980
40. M. Waern, E. Rubenowitz, and B. Runeson Burden of illness and suicide in elderly people: case-control study BMJ 324 2002 1355
41. Centers for Medicare and Medicaid Services. CMS Manual System. Pub 100-02 Medicare Benefit Policy: transmittal 5, Change request 2859 & 2779. 220-Coverage of outpatient physical therapy, occupational therapy, and speech-language pathology services under medical insurance. January 4, 2009. Available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2004-Transmittals-Items/CMS044028.html. Accessed May 8, 2014.
42. J. Unützer, M. Schoenbaum, and W.J. Katon Healthcare costs associated with depression in medically ill fee-for-service Medicare participants J Am Geriatr Soc 57 2009 506 510